A transformative advance in genome editing technology reports that wrapping CRISPR components in DNA-coated nanoparticles significantly enhances editing efficiency, tripling successful gene alterations compared to traditional delivery systems. This breakthrough addresses key delivery challenges, improving precision and expanding therapeutic potential across genetic diseases and oncology. The innovation promises to accelerate clinical translation of CRISPR-based therapies.